Akero Therapeutics Inc buy Bank of America Co.
Start price
27.05.25
/
50%
€42.17
Target price
27.05.26
€56.17
Performance (%)
11.38%
End price
28.05.26
-
Summary
This prediction is currently being closed. The BUY prediction by Bank_of_America_Co_ currently has a performance of 11.38%. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | - | - | - |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target raised by analysts at Bank of America Co. from $63.00 to $64.00. They now have a "buy" rating on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten